N4 Pharma Plc (AIM:N4P)

London flag London · Delayed Price · Currency is GBP · Price in GBX
0.4750
+0.0250 (5.26%)
Jun 6, 2025, 4:35 PM GMT+1
-24.00%
Market Cap 3.95M
Revenue (ttm) 5.86K
Net Income (ttm) -1.08M
Shares Out 832.28M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,186,830
Average Volume 1,204,301
Open 0.4653
Previous Close 0.4750
Day's Range 0.4500 - 0.5000
52-Week Range 0.3500 - 0.8000
Beta 0.63
RSI 55.24
Earnings Date Jun 24, 2025

About N4 Pharma

N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery systems to enhance the cellular delivery of cancer treatments, gene therapy, and vaccines in the United Kingdom. It develops Nuvec, which offers silica nanoparticles with irregular surface structure and polyethyleneimine that traps and protects nucleic acid; and Liptide, a platform to deliver a proprietary siRNA sequence to silence a fibrotic gene for the treatment of glaucoma. The company was incorporated in 1979 and is based in London, the United Kingdom... [Read more]

Sector Healthcare
Founded 1979
Employees 5
Stock Exchange London Stock Exchange AIM
Ticker Symbol N4P
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.